Bluewater Bio provides proprietary water and wastewater treatment technologies for municipal and industrial clients, focusing on efficiency and environmental sustainability. The company was founded in 2007 by Daniel Charles Ishag and is headquartered in London, UK.
Since a new management team led by Executive Chairman and CEO Richard Haddon took over in 2015, the company has undergone a significant turnaround, focusing its strategy on core technologies and key markets. This strategic shift moved the company from being solely a technology provider to a holistic solutions provider, often acting as a Tier 1 contractor, particularly in overseas markets.
Bluewater Bio's business model involves providing engineering, procurement, and construction (EPC) services, technology supply, and increasingly, operational and maintenance services to generate recurring revenue. The company serves clients globally, with a strong focus on the UK and the Middle East, addressing issues of water scarcity and tightening environmental standards.
The company's core proprietary technologies are HYBACS® (Hybrid Activated Sludge process) and FilterClear™, a high-throughput multimedia filtration system. HYBACS® upgrades existing activated sludge processes, enabling treatment plants to handle significantly increased loads within their existing footprint. FilterClear™ is a high-rate multimedia filtration technology used for tertiary sewage filtration, desalination pre-treatment, and industrial process water. The portfolio also includes technologies like NeoTech™ UV disinfection and CFIC® moving bed bioreactor (MBBR). These solutions are designed to reduce capital and operational costs, energy consumption, and environmental footprint compared to conventional methods.
The company has secured major contracts, notably in Bahrain, where it is involved in upgrading a significant portion of the kingdom's wastewater treatment capacity. Bluewater Bio has been recognized as one of the fastest-growing water technology companies in Europe and received the Queen's Award for Enterprise for International Trade. The company's investors include Ombu Group, Hermes GPE, and Salica Investments.
Keywords: wastewater treatment, water technology, HYBACS, FilterClear, EPC contractor, municipal wastewater, industrial wastewater, water reuse, sludge treatment, biological nutrient removal, multimedia filtration, UV disinfection, desalination pre-treatment, phosphorus removal, environmental technology, water management solutions, activated sludge process, water scarcity solutions, sustainable water development, advanced water treatment
Dealroom maps Bluewater Bio's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
7team members profilednamed & role-tagged by Dealroom
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Market sentiment
What the market is saying about Bluewater Bio
An AI-synthesized read of the highest-engagement posts about Bluewater Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bluewater Bio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
B
